Since its formation in 1992, Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. The test kits manufactured by Trinity Biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. The company is also a significant provider of raw materials to the life sciences industry. Trinity Biotech, which has its headquarters in Ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 110 countries around the world. It reaches this worldwide market by combining the skills of its own sales force with a network of international distributors and strategic partners.
"A Trinity Biotech Company"
Autoimmune and Immunogenetics Testing Services
Immco Diagnostics Reference Laboratory, located in Buffalo, NY, USA is licensed throughout the United States for testing serology, biopsy and genetic specimens. Our lab specializes in diagnostics for autoimmune disease such as Sjögren’s syndrome, Thyroiditis, Rheumatoid Arthritis, Type 1 Diabetes, Celiac Disease, Ulcerative Colitis, Crohn’s Disease, Systemic Lupus Erythematosus, and Scleroderma and immunogenetics for support of organ and tissue donation and transplant.
In addition, Immco’s immunogenetics division provides HLA tissue typing for select alleles to determine susceptibility to specific ailments and a means of assessing familial risk associated with these disorders.
Our immunopathologists have extensive clinical diagnostic and diagnostic pathology experience. We are known for high quality and accurate diagnostic reports and keen customer service. For most tests we provide 48 hour turnaround time to our clients and consultations on autoimmune diseases and micrographs.
Our expert pathologists are certified by the American Board of Oral and Maxillofacial Pathology, American Board of Dermatopathology, the American Board of Medical Laboratory Immunology, and the National Registry of Clinical Chemistry
Located across Europe and North America our Centres of Excellence are responsible for the manufacture of products designed to bring improvements to the quality of life for millions of people around the world.
Trinity Biotech’s central manufacturing site specialises in the production of the Point of Care, RIA, Clinical Chemistry and Immunofluorescence ranges.
Carlsbad, California, USA
Our Carlsbad site specialises in the development and production of Western Blots, Point of Care assays, Infectious Disease Reagents and other immunofluorescence products
Acton, Massachusetts, USA
Our Acton site handles the supply of diagnostic raw materials to the research and diagnostics industry.
Jamestown, New York, USA
Our Jamestown site specialises in the production of EIA assays and instrumentation mainly for infectious disease and autoimmune applications.
Kansas City, Missouri, USA
The Kansas City site is the production facility for Diabetes Diagnostics based on Boronate Affinity HPLC.
Amherst, New York, USA
Our Amherst site specialises in the development and manufacture of EIAs, Western blots, Line immunoassays and immunofluorescence products for autoimmune diseases.
Buffalo, New York, USA
The Reference laboratory of Immco diagnostics is also located at our Buffalo site
The Uppsala site focuses on the development of assays for cardiac markers on our Meritas point of care platform.
Burlington, ON, Canada
Our Burlingtion site focuses on the cloning, expression and purification of commercial and novel proteins as well as the design and synthesis of antigenic targets for immunoassays.